$CRSP News Article - Vertex and CRISPR Therapeutics Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to CTX001(TM) for Transfusion-Dependent Beta Thalassemia
https://marketwirenews.com/news-releases/vert...17375.html